Liver cancer rates have more than tripled in the U.S. since 1980 and continue to rise. More than 41,000 people will be diagnosed with liver cancer in the U.S. this year, and about 29,000 will die from the disease, according ...
Dec 13, 2023
0
0
A simple, widely used test developed by a Virginia Commonwealth University researcher to predict advanced liver disease can also predict which COVID-19 patients might need a respirator, with patients higher on the scale almost ...
Dec 13, 2023
0
0
Non-alcoholic fatty liver disease (NAFLD), characterized by excessive hepatic lipid accumulation, poses a high prevalence and can progress to cirrhosis and liver cancer. To enhance preventive and therapeutic efforts, an in-depth ...
Dec 11, 2023
0
0
Mortality related to end stage liver disease is ranked as the 12th most common cause of death in the U.S. Liver transplantation remains the only treatment for end stage liver disease, but there is a critical shortage of organ ...
Dec 7, 2023
0
24
The global rise in obesity and diabetes is leading to an epidemic in fatty liver disease affecting 20%–30% of the world's population. Almost a third of people with fatty liver disease go on to develop an advanced form of ...
Dec 7, 2023
0
0
Aging is associated with chronic, nonresolving inflammation, or "inflammaging," that can lead to tissue dysfunction. New findings reported in The American Journal of Pathology reveal insights into the cellular programs and ...
Dec 6, 2023
0
0
Non-alcoholic fatty liver disease (NAFLD) is a major health problem affecting approximately 30% of people in Western countries and which has been in sharp increase over the last three decades.
Dec 5, 2023
0
2
A breakthrough in the understanding of the relationship between a naturally occurring enzyme and the liver cancer drug sorafenib could improve the effectiveness of the drug, which currently prolongs the life of liver cancer ...
Dec 4, 2023
0
53
New research delves into a traditionally overlooked category of chronic hepatitis B (CHB) patients. While those who are HBeAg-negative with normal ALT levels have been considered low-risk and often excluded from immediate ...
Dec 1, 2023
0
0
A new study published in the journal eGastroenterology provides an updated assessment of the diagnosis, pathophysiology, and treatment of hepatorenal syndrome-acute kidney injury (HRS-AKI). This severe and often fatal condition ...
Nov 30, 2023
0
0
